ADMA Biologics

ADMA Biologics is an end-to-end commercial biopharmaceutical company leading a new era in the manufacturing, marketing, and commercialization of specialized plasma-derived products for the prevention and treatment of infectious diseases in immunocompromised patients and others at risk for certain infections. Our dedication to these underserved populations drives us, and our hands-on approach to production and development sets us apart. With three FDA-approved products, including ASCENIV™ (Immune Globulin Intravenous, Human), BIVIGAM® (Immune Globulin Intravenous, Human), and NABI-HB® (Hepatitis B Immune Globulin, Human), ADMA's mission is to continue the successful development and commercialization of plasma-derived human immune globulins targeting specific patient populations for the treatment and prevention of certain infectious diseases and the management of immunocompromised patient groups.